Contralateral lymph node metastasis in recurrent ipsilateral breast cancer with Lynch syndrome: a locoregional event
- Author(s)
- Zwimpfer, TA; Schwab, FD; Steffens, D; Kaul, F; Schmidt, N; Geiger, J; Geissler, F; Heinzelmann-Schwarz, V; Weber, WP; Kurzeder, C;
- Journal Title
- World Journal of Surgical Oncology
- Publication Type
- Case report
- Abstract
- INTRODUCTION: Contralateral axillary lymph node metastasis (CALNM) in breast cancer (BC) is considered a distant metastasis, marking stage 4cancer. Therefore, it is generally treated as an incurable disease. However, in clinical practice, staging and treatment remain controversial due to a paucity of data, and the St. Gallen 2021 consensus panel recommended a curative approach in patients with oligometastatic disease. Aberrant lymph node (LN) drainage following previous surgery or radiotherapy is common. Therefore, CALNM may be considered a regional event rather than systemic disease, and a re-sentinel procedure aided by lymphoscintigraphy permits adequate regional staging. CASE REPORT: Here, we report a 37-year-old patient with Lynch syndrome who presented with CALNM in an ipsilateral relapse of a moderately differentiated invasive ductal BC (ER 90%, PR 30%, HER2 negative, Ki-67 25%, microsatellite stable), 3 years after the initial diagnosis. Lymphoscintigraphy detected a positive sentinel LN in the contralateral axilla despite no sign of LN involvement or distant metastases on FDG PET/CT or MRI. The patient underwent bilateral mastectomy with sentinel node dissection, surgical reconstruction with histological confirmation of the CALNM, left axillary dissection, adjuvant chemotherapy, and anti-hormone therapy. In addition to her regular BC follow-up visits, the patient will undergo annual colonoscopy, gastroscopy, abdominal, and vaginal ultrasound screening. In January 2023, the patient was free of progression for 23 months after initiation of treatment for recurrent BC and CALNM. CONCLUSION: This case highlights the value of delayed lymphoscintigraphy and the contribution of sentinel procedure for local control in the setting of recurrent BC. Aberrant lymph node drainage following previous surgery may be the underlying cause of CALNM. We propose that CALNM without evidence of systemic metastasis should be considered a regional event in recurrent BC, and thus, a curative approach can be pursued. The next AJCC BC staging should clarify the role of CALNM in recurrent BC to allow for the development of specific treatment guidelines.
- Publisher
- BioMed Central
- Keywords
- Humans; Female; Adult; *Breast Neoplasms/pathology; Lymphatic Metastasis/pathology; Sentinel Lymph Node Biopsy/methods; Mastectomy; *Colorectal Neoplasms, Hereditary Nonpolyposis/surgery/pathology; Positron Emission Tomography Computed Tomography; Neoplasm Recurrence, Local/diagnostic imaging/surgery; Lymph Node Excision; Lymph Nodes/surgery/pathology; Recurrence; Axilla/pathology
- Department(s)
- Medical Oncology
- PubMed ID
- 36755294
- Publisher's Version
- https://doi.org/10.1186/s12957-023-02918-w
- Open Access at Publisher's Site
https://doi.org/10.1186/s12957-023-02918-w- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2023-06-15 07:25:02
Last Modified: 2023-06-15 07:25:48